Evidence map›Paper›PMID 23645855›Full record

ReviewCold Spring Harbor perspectives in medicine2013

Cell-free hemoglobin and its scavenger proteins: new disease models leading the way to targeted therapies.

Dominik J Schaer, Paul W Buehler

Open access · bronzeAbstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 94 citations in OpenAlex.

  1. Review
  2. Article
  3. Bimodal distribution of trauma-related acute kidney injury (TrAKI): A clinical review.Journal of critical care medicine (Universitatea de Medicina si Farmacie din Targu-Mures) · 2026
    Review
  4. The role of mediastinal blood in the development of postoperative atrial fibrillation after cardiac surgery.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. AI-Based Metamaterial Design.ACS applied materials & interfaces · 2024
    Review
  9. Heme (dys)homeostasis and liver disease.Frontiers in physiology · 2024
    Review
  10. Article
  11. Article
  12. Interleukin-10 attenuates renal injury after myocardial infarction in diabetes.Journal of investigative medicine : the official publication of the American Federation for Clinical Research · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Nitric oxide and sickle cell disease-Is there a painful connection?Experimental biology and medicine (Maywood, N.J.) · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Dominik J SchaerDivision of Internal Medicine, University Hospital, Zurich CH-8091, Switzerland. dominik.schaer@usz.ch
Paul W Buehler
Center for Biologics Evaluation and Research · USUniversity of Zurich · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hemoglobin (Hb) has multiple pathophysiologic effects when released into the intravascular space during hemolysis. The extracellular effects of Hb have resulted in novel models of toxicity, which help to explain endothelial dysfunction and cardiovascular complications that accompany genetic hemolytic anemias, malaria, blood transfusion, and atherosclerosis. The majority of models focus on nitric oxide (NO) depletion; however, in local tissue environments, Hb can also act as a pro-oxidant and inflammatory agent. This can alter cellular differentiation with the potential to deviate immune responses. The understanding of these mechanisms set in the context of natural scavenger and detoxification systems may accelerate the development of novel treatment strategies.

Indexed as

Anemia, Sickle CellAnimalsAntigens, CDAntigens, Differentiation, MyelomonocyticAtherosclerosisCD163 AntigenErythrocyte TransfusionHeme Oxygenase (Decyclizing)HemoglobinsHemolysisHemopexinHumansHypertension, PulmonaryMalariaNitric OxideOxidation-ReductionAntigens, CDAntigens, Differentiation, MyelomonocyticCD163 AntigenHeme Oxygenase (Decyclizing)HemoglobinsHemopexinNitric OxideReceptors, Cell SurfaceReceptors, Scavenger

Identifiers

PMID23645855
PMCPMC3662353
OpenAlexW2145152179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.